Learn More
Medchemexpress LLC Phenol, 4-[3-[1,3-dihydro-5-(methylsulfonyl)-2H-isoindol-2-yl]-3-methylbutyl]-2-(1,1-dimethylethoxy)- | 1802632-22-9 | 99.0% | 431.59 | 25 MG

Supplier: Medchemexpress LLC 25MGHY111669
Zervimesine (CT1812) is an orally active and brain penetrant sigma-2 receptor antagonist with a Ki of 8.5 nM. It can be used for the research of Alzheimer's disease. It has the potential for research in Alzheimer's disease, including the reversal and prevention of amyloid beta oligomer-induced vesicular membrane trafficking in Sprague-Dawley rat neurons.
- Orally active and brain penetrant sigma-2 receptor antagonist
- Ki of 8.5 nM for sigma-2 receptor
- Displaces and prevents Aβ oligomer binding in neurons and glia
- Increases synaptic number and protein expression in neurons
- Selectively reduces Aβ oligomer extracellular concentrations in transgenic hAPP/PS1 mice
- Improves cognitive performance in transgenic Thy1 huAPPSwe/Lnd+ male mice
- Appearance: Solid
- Color: White to off-white
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.